Ophthalmic Artery Chemosurgery for Retinoblastoma Prevents New Intraocular Tumors
Objective:
To determine the incidence and timing of new intraocular tumor foci in genetic retinoblastoma cases after treatment with ophthalmic artery chemosurgery (OAC).
Design:
Single-center retrospective review of all genetic retinoblastoma cases managed at Memorial Sloan-Kettering Cancer Center/Weil-Cornell Medical School since May 2006.
Participants:
Eighty-one patients (80 with bilateral disease and 1 with unilateral disease with a family history) with genetic retinoblastoma, with a total of 116 eyes treated with OAC since May 2006.
Methods:
Retrospective, single-institution review of patients with bilateral retinoblastoma and unilateral retinoblastoma with a positive family (Read more...)